These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23229638)

  • 1. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.
    Reginald K; Eckl-Dorna J; Zafred D; Focke-Tejkl M; Lupinek C; Niederberger V; Keller W; Valenta R
    Immunol Cell Biol; 2013 Feb; 91(2):167-72. PubMed ID: 23229638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation.
    Villazala-Merino S; Rodriguez-Dominguez A; Stanek V; Campion NJ; Gattinger P; Hofer G; Froeschl R; Fae I; Lupinek C; Vrtala S; Breiteneder H; Keller W; Perkmann T; Nakamura R; Pickl WF; Valenta R; Eckl-Dorna J; Niederberger V
    J Allergy Clin Immunol; 2020 Mar; 145(3):958-967.e5. PubMed ID: 31775017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules.
    Pree I; Shamji MH; Kimber I; Valenta R; Durham SR; Niederberger V
    Clin Exp Allergy; 2010 Sep; 40(9):1346-52. PubMed ID: 20604801
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
    Front Immunol; 2020; 11():2118. PubMed ID: 33013894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
    Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
    J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1-specific IgE binding of birch pollen.
    Seutter von Loetzen C; Reuter A; Spiric J; Schulenborg T; Bellinghausen I; Völker E; Vogel L; Rösch P; Schiller D
    Clin Exp Allergy; 2019 May; 49(5):712-723. PubMed ID: 30706562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
    Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
    J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer.
    Campana R; Vrtala S; Maderegger B; Dall'Antonia Y; Zafred D; Blatt K; Herrmann H; Focke-Tejkl M; Swoboda I; Scheiblhofer S; Gieras A; Neubauer A; Keller W; Valent P; Thalhamer J; Spitzauer S; Valenta R
    Mol Immunol; 2011 Jan; 48(4):431-41. PubMed ID: 21093057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive assay for the detection of IgE bound to the major birch pollen allergen, Bet v 1, in the form of immune complexes.
    Pree I; Reisinger J; Bohle B; Frantal S; Valenta R; Niederberger V
    J Immunol Methods; 2009 Jun; 345(1-2):100-5. PubMed ID: 19376122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
    Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
    PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
    Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
    J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.
    Selb R; Eckl-Dorna J; Neunkirchner A; Schmetterer K; Marth K; Gamper J; Jahn-Schmid B; Pickl WF; Valenta R; Niederberger V
    J Allergy Clin Immunol; 2017 Jan; 139(1):290-299.e4. PubMed ID: 27372566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro model for the allergen-IgE-FcARI interaction.
    Laffer S; Hogbom E; Adrianson J; Grönlund H; Sillaber C; Valent P; Vangelista L; Kricek F; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1999; 118(2-4):116-8. PubMed ID: 10224355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapy.
    Selb R; Eckl-Dorna J; Vrtala S; Valenta R; Niederberger V
    Allergy; 2013 Sep; 68(9):1199-202. PubMed ID: 23998344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical and direct involvement of the CD23 stalk region in IgE binding.
    Selb R; Eckl-Dorna J; Twaroch TE; Lupinek C; Teufelberger A; Hofer G; Focke-Tejkl M; Gepp B; Linhart B; Breiteneder H; Ellinger A; Keller W; Roux KH; Valenta R; Niederberger V
    J Allergy Clin Immunol; 2017 Jan; 139(1):281-289.e5. PubMed ID: 27343203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE.
    Zghaebi M; Byazrova M; Flicker S; Villazala-Merino S; Campion NJ; Stanek V; Tu A; Breiteneder H; Filatov A; Khaitov M; Niederberger-Leppin V; Eckl-Dorna J; Valenta R
    Front Immunol; 2021; 12():803236. PubMed ID: 34987522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.
    Svenson M; Jacobi HH; Bødtger U; Poulsen LK; Rieneck K; Bendtzen K
    Mol Immunol; 2003 Jan; 39(10):603-12. PubMed ID: 12431394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE and allergen-specific immunotherapy-induced IgG
    Groh N; von Loetzen CS; Subbarayal B; Möbs C; Vogel L; Hoffmann A; Fötisch K; Koutsouridou A; Randow S; Völker E; Seutter von Loetzen A; Rösch P; Vieths S; Pfützner W; Bohle B; Schiller D
    Clin Exp Allergy; 2017 May; 47(5):693-703. PubMed ID: 27770477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.